510(k) · Cleared
ClearedU2 Femoral Component, CR, Porous Coated, Additional Sizes
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
United Orthopedic Corporation · MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer
Cleared on Sep 25, 2015 as substantially equivalent to K140075 (United Orthopedic Corp., 2014) after a 179-day review. Its family tree reaches back 3 generations to 1995. 2 later devices descend from it.
- Decided
- Sep 25, 2015
- Review
- 179 days
- Class
- Class II
- Product code
- MBH
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K951987 (1995). 6 ancestors in all. 2 later devices descend from it, 1 citing it directly.
- Root · 3 generations backK951987 Genesis II Total Knee SystemSmith & Nephew Richards, Inc. · 1995 · Recalled
- 2 generations backK030612 Genesis II Total Knee SystemSmith & Nephew, Inc. · 2003
- 1 generation backK140075 U2 Femoral Component, CR, Porous CoatedUnited Orthopedic Corp. · 2014
- This deviceK150832 U2 Femoral Component, CR, Porous Coated, Additional SizesUnited Orthopedic Corporation · 2015
- Descendant · cites it directly · 1 of its ownK221705 U2 Total Knee System-PF+United Orthopedic Corporation · 2023
- Descendant · 2 generations on · 0 of its ownK243656 U2 Total Knee System – PF+ Patella; USTAR II System– PF+ PatellaUnited Orthopedic Corporation · 2025
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K951987 | Genesis II Total Knee System | Smith & Nephew Richards, Inc. | 1995 | 6 |
| −2 | K030612 | Genesis II Total Knee System | Smith & Nephew, Inc. | 2003 | — |
| −1 | K140075 | U2 Femoral Component, CR, Porous Coated | United Orthopedic Corp. | 2014 | — |
| 0 (this device) | K150832 | U2 Femoral Component, CR, Porous Coated, Additional Sizes | United Orthopedic Corporation | 2015 | — |
| +1 | K221705 | U2 Total Knee System-PF+ | United Orthopedic Corporation | 2023 | — |
| +2 | K243656 | U2 Total Knee System – PF+ Patella; USTAR II System– PF+ Patella | United Orthopedic Corporation | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 2002 | 1 | 0 |
| 2006 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MBH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MBH device
- #1 K241597 Freedom® Total Knee System - Porous Tibial…score 19.9 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K140075 | U2 Femoral Component, CR, Porous CoatedSummary page 4…Orthopaedics Device Device Product Code: MBH Predicate Device: “UNITED” U2 Femoral Component, CR, Porous Coated (K140075) Device Description: U2 Femoral Component, CR, Porous Coated, Additional Sizes is an extension of cleared “UNITED” U2 Femoral C… | 2014 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K221705 | U2 Total Knee System-PF+ | 2023 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 7.8 years on median.
- 2 of the 6 ancestors have a recall of any class.
- Of its descendants, K221705 (United Orthopedic Corporation, 2023) has gone furthest, with 1 descendant of its own.
- 1 other device also cites its predicate K140075.
How does its category compare?
All MBH devicesMBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.
FDA decisions per year · MBH
8in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MBH
98in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MBH
1in 2024
Class I (5 since 2007) Class II/III not classified
Adverse event reports per year · MBH
1,561in 2025
MAUDE reports naming product code MBH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 59 | 0 | 27 |
| 2008 | 3 | 70 | 0 | 21 |
| 2009 | 3 | 209 | 2 | 89 |
| 2010 | 4 | 84 | 0 | 121 |
| 2011 | 5 | 84 | 15 | 247 |
| 2012 | 5 | 90 | 1 (1) | 370 |
| 2013 | 6 | 138 | 4 (4) | 308 |
| 2014 | 9 | 114 | 0 | 385 |
| 2015 | 8 | 100 | 0 | 955 |
| 2016 | 4 | 74 | 1 | 1,034 |
| 2017 | 4 | 115 | 9 | 1,007 |
| 2018 | 6 | 89 | 1 | 1,191 |
| 2019 | 1 | — | 1 | 1,394 |
| 2020 | 7 | 112 | 2 | 1,089 |
| 2021 | 6 | 48 | 0 | 1,539 |
| 2022 | 7 | 57 | 0 | 1,261 |
| 2023 | 6 | 94 | 2 | 1,263 |
| 2024 | 10 | 84 | 1 | 1,497 |
| 2025 | 8 | 98 | 0 | 1,561 |
| 2026 | 7 | 153 | 4 | — |
What is it indicated for?
The U2 Total Knee system is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis, osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle or pseudogout, posttraumatic loss of joint configuration, particularly when there is patellofemoral…
Read the full statement (113 words)
The U2 Total Knee system is indicated in knee arthroplasty for reduction or relief of pain
and/or improved knee function in skeletally mature patients with severe knee pain and
disability due to rheumatoid arthritis, osteoarthritis, primary and secondary traumatic
arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle or
pseudogout, posttraumatic loss of joint configuration, particularly when there is
patellofemoral erosion, dysfunction or prior patellectomy, moderate valgus, varus, or
flexion deformities. This device may also be indicated in the salvage of previously failed
surgical attempts if the knee can be satisfactorily balanced and stabilized at the time of
surgery. This device is a single use implant and intended for cementless use only.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K150832 · printed Nov 5, 2026
Cite this page
510(k) Report. “K150832: U2 Femoral Component, CR, Porous Coated, Additional Sizes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K150832
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026